Emily Area, Barclays’ head of European pharmaceutical analysis, reacts to the selloff in Novo Nordisk’s shares after its experimental weight problems shot CagriSema failed to satisfy expectations. She speaks on “Bloomberg Open Curiosity.”
Join the Prognosis publication to get the most recent in well being, medication and science — and what it means for you — from Bloomberg’s world group of well being reporters: https://bloom.bg/3R4V5hE
——–
Extra on Bloomberg Tv and Markets
Like this video? Subscribe and activate notifications so you do not miss any movies from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9
Go to http://www.bloomberg.com for enterprise information & evaluation, up-to-the-minute market knowledge, options, profiles and extra.
Join with Bloomberg Tv on:
X: https://twitter.com/BloombergTV
Fb: https://www.fb.com/BloombergTelevision
Instagram: https://www.instagram.com/bloombergtv/
Join with Bloomberg Enterprise on:
X: https://twitter.com/enterprise
Fb: https://www.fb.com/bloombergbusiness
Instagram: https://www.instagram.com/bloombergbusiness/
TikTok: https://www.tiktok.com/@bloombergbusiness?lang=en
Reddit: https://www.reddit.com/r/bloomberg/
LinkedIn: https://www.linkedin.com/firm/bloomberg-news/
Extra from Bloomberg:
Bloomberg Radio: https://twitter.com/BloombergRadio
Bloomberg Surveillance: https://twitter.com/bsurveillance
Bloomberg Politics: https://twitter.com/bpolitics
Bloomberg Originals: https://twitter.com/bbgoriginals
Watch extra on YouTube:
Bloomberg Expertise: https://www.youtube.com/@BloombergTechnology
Bloomberg Originals: https://www.youtube.com/@enterprise
Bloomberg Quicktake: https://www.youtube.com/@BloombergQuicktake
Bloomberg Espanol: https://www.youtube.com/@bloomberg_espanol
Bloomberg Podcasts: https://www.youtube.com/@BloombergPodcasts
